# Therapeutic Instillation of Mistletoe

> **NCT02106572** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Abnoba Gmbh** · enrollment: 548 (estimated)

## Conditions studied

- Superficial Bladder Cancer

## Interventions

- **DRUG:** abnobaVISCUM 900
- **DRUG:** Mitomycin C

## Key facts

- **NCT ID:** NCT02106572
- **Lead sponsor:** Abnoba Gmbh
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-04
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 548 (ESTIMATED)
- **Last updated:** 2025-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02106572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02106572, "Therapeutic Instillation of Mistletoe". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02106572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*